問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberMCCD09013B

2010-06-01 - 2011-12-31

Phase III

Terminated1

Study ended13

ICD-10E11.9

Type 2 diabetes mellitus without complications

ICD-10E13.9

Other specified diabetes mellitus without complications

ICD-9250.00

Diabetes mellitus without mention of complication, Type II [non-insulin dependent type][NIDDM type] [ adult-onset type] or unspecified type, not stated as uncontrolled

  • Trial Applicant

    PROTECH PHARMASERVICES CORPORATION

  • Sponsor

  • Trial scale

    Taiwan Multiple Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator 許惠恒

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 洪乙仁

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator Ching Fai Kwok

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 楊純宜

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 陳榮福

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 林慶齡

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 杜思德

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 黃建寧

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 裴馰

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator Jui-Hung Sun

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator Ching-Chu Chen

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 盧永川

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 簡銘男 Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Study ended

Principal Investigator 簡銘男 Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    220 participants

  • Global

    220 participants